Surgery Partners, Inc. (SGRY) Tops Q1 EPS by 2c, provides guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q1 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $717.4 million versus the consensus estimate of $700.01 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2024 revenue of $3.05 billion, versus the consensus of $3.007 billion. And at least $505 million in Adjusted EBITDA

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)